Robbie Majzner

24PUBLICATIONS
161CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyEvolutionary biology not elsewhere classifiedTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 23, 2025
Engineering T cells with a membrane-tethered version of SLP-76 overcomes antigen-low resistance to CAR T cell therapy.

Maria Caterina Rotiroti, Aidan M Tousley, Hoyin Chu

|Apr 23, 2025
IKAROS levels are associated with antigen escape in CD19- and CD22-targeted therapies for B-cell malignancies.

Pablo Domizi, Jolanda Sarno, Astraea Jager

|Nov 29, 2024
Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M<sup>+</sup> diffuse midline gliomas.

Michelle Monje, Jasia Mahdi, Robbie Majzner

|Nov 13, 2024
Intravenous and intracranial GD2-CAR T cells for H3K27M<sup>+</sup> diffuse midline gliomas.

Michelle Monje, Jasia Mahdi, Robbie Majzner

|Oct 25, 2024
Orientation-dependent CD45 inhibition with viral and engineered ligands.

Marta T Borowska, Liu D Liu, Nathanael A Caveney

|May 27, 2024
Immunotherapy-related cognitive impairment after CAR T cell therapy in mice.

Anna C Geraghty, Lehi Acosta-Alvarez, Maria Rotiroti

Pageof 4

Frequent Collaborators

10 joint publications

Crystal Mackall

8 joint publications

Michelle Monje

7 joint publications

Ansuman T Satpathy

6 joint publications

Kara L Davis